Q6: Can dementia be diagnosed at first or second level care by non-specialist health care providers? What should be the assessment process for the diagnosis of dementia?
Q4: For people with dementia with associated depression, do antidepressants when compared to placebo/comparator produce benefits/harm in the specified outcomes?
Q7: For people with dementia, who should be told of the diagnosis and how should the diagnosis be delivered?
November 3, 2009https://doi.org/10.1371/journal.pmed.1000176
PLoS Med 6(11): e1000176. https://doi.org/10.1371/journal.pmed.1000176
Este manual ha sido desarrollado como una herramienta de auto-ayuda para cuidadores de personas con demencia. Cada módulo está dividido en lecciones
individuales. Cada lección está estructurada de la misma forma:
1. Al inicio se encuentra un resumen de porqué esa lección es importante,
2. ...Cómo la lección te ayudará como cuidador y
3. Lo que aprenderás en ella.
Cada lección contiene una mezcla de información resumida, ejemplos descriptivos, preguntas de respuesta múltiple y actividades para practicar lo aprendido. Así
podrás encontrar ejercicios y actividades individuales que te permitirán comprobar tu comprensión y reflexionar sobre tu aprendizaje de forma práctica.
more
Problems with care for older people with dementia in Australia “Fading Away”: How Aged Care Facilities in Australia Chemically Restrain Older People with Dementia
ADI is the international federation of Alzheimer associations around the world, in official relations with the World Health Organization. Each member is the Alzheimer association in their country who support people with dementia and their families. ADI's vision is prevention, care and inclusion toda...y, and cure tomorrow
Here you can find import guidelines, case studies worldwide, dementia friendly plans, training material, IEC Material, etc.
more
The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. These WHO Guidelines are an important tool for health care providers as well as governments, pol...icy-makers and other stakeholders to strengthen their response to the dementia challenge.
Executive Summary available in Arabic, Chinese, French, Russian and Spanish at: https://www.who.int/mental_health/neurology/dementia/guidelines_risk_reduction/en/
more
16-17 march 2015, Geneva, Switzerland
Meeting report
Q10: For carers of people with dementia, does respite care when compared to care as usual, produce benefits/harm in the specified outcomes?
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
2017 - 2025
Accessed: 06.03.2019
2017-2025
Accessed: 06.03.2019
Progress towards targets of the Global action plan on dementia
Areas for action include: increasing prioritisation and awareness of dementia; reducing the risk of dementia; diagnosis, treatment and care; support for dementia carers; strengthening information systems for dementia; and research and innovation.
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
Trials (2018) 19:271 https://doi.org/10.1186/s13063-018-2604-9
Based on the findings of this trial, we will examine the potential use and scale up of iSupport for caregiver distress in India. This style of online self-help programs could be expanded to other regions or countries or to other suitabl...e caregiver groups
more